Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.5%
Mon, 22 Jul 10:5

ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.5%Image source: DNY59/www.istockphoto.com

ALEMBIC PHARMA share price has zoomed 5% and is presently trading at Rs 1,133.7.

Meanwhile, the BSE HEALTHCARE index is at 38,340.0 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are DR. LAL PATHLABS (up 2.5%) and POLY MEDICURE (up 1.7%).

Jubilant Pharmova (down 2.9%) and ASTER DM HEALTHCARE (down 1.1%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 658.4 to Rs 1,133.7, registering a gain of Rs 475.3 (up 72.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,342.4 to 38,340.0, registering a gain of 45.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 94.7%), Lupin (up 93.5%) and Cadila Healthcare (up 93.2%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,572.5 .

The top losers among the BSE Sensex today are Reliance Ind. (down 2.8%) and Kotak Bank (down 2.6%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,534.0 . NTPC and HDFC Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,795.1 to 80,572.5, registering a gain of 13,777.3 points (up 20.6%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 10.9% YoY to Rs 1,786 million for the quarter ended March 2024, compared to a profit of Rs 1,611 million a year ago. Net sales rose 7.9% to Rs 15,170 million during the period as against Rs 14,065 million in January-March 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 36.1.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.5%". Click here!